Stay updated on NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This change affects only the page revision label and does not alter study content or patient-facing information.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:08.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new page revision tag 'Revision: v3.4.2' has been added, and older notices including 'Revision: v3.4.1' and a government funding status notice have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:33:18.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new site-wide notice about a lapse in government funding and the NIH Clinical Center status has been added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:13:02.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and a new QC-status label ('Last Update Submitted that Met QC Criteria') with revision v3.4.0. The older QC label ('Last Update Submitted that met QC Criteria'), the No FEAR Act data item, and the older revision tag (v3.3.4) were removed or updated.
    Difference
    0.2%
    Check dated 2026-01-28T05:59:37.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A minor revision update was made to the page: Revision: v3.3.4 added and Revision: v3.3.3 removed, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:01:19.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer now displays 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' link and the older 'Revision: v3.3.2' link were removed.
    Difference
    0.1%
    Check dated 2025-12-23T17:13:05.000Z thumbnail image

Stay in the know with updates to NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.